Medpace Holdings (MEDP) earnings
Medpace Holdings (MEDP) reported net income of $451.12M in fiscal 2025 (the year ended December 31, 2025). That is 11.6% higher than the $404.39M of fiscal 2024. Figures as of 18 Nov 2026, 04:35 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Earnings (net income), fiscal 2025
- $451.12M
- Change on fiscal 2024
- +11.6%
- Growth, 5 years
- +25.4% a year
- Highest on record
- $451.12Mfiscal 2025
- Lowest on record
- -$8.67Mfiscal 2015
- Fiscal years on record
- 112015–2025
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.
Medpace Holdings earnings, in more detail
Over the five fiscal years to 2025 net income grew at a compound 25.4% a year. Across the 11 fiscal years on record (2015–2025), the highest was $451.12M in fiscal 2025 and the lowest -$8.67M in fiscal 2015.
Earnings (net income) by fiscal year
Medpace Holdings earnings, year by year
| Fiscal year | Earnings (net income) | Change | Year ended |
|---|---|---|---|
| 2025 | $451.12M | 11.6% up | |
| 2024 | $404.39M | 43.0% up | |
| 2023 | $282.81M | 15.3% up | |
| 2022 | $245.37M | 34.9% up | |
| 2021 | $181.85M | 25.1% up | |
| 2020 | $145.38M | 44.7% up | |
| 2019 | $100.44M | 37.2% up | |
| 2018 | $73.19M | 87.1% up | |
| 2017 | $39.12M | 191.4% up | |
| 2016 | $13.43M | — | |
| 2015 | -$8.67M | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.
How to read it
Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.
Earnings (net income) at health care companies of similar size
| Company | Earnings (net income) | Fiscal year |
|---|---|---|
| Alnylam Pharmaceuticals ALNY | $313.75M | 2025 |
| Zimmer Biomet Holdings ZBH | $705.10M | 2025 |
| Medpace Holdings MEDP | $451.12M | 2025 |
| Revvity RVTY | $241.20M | 2025 |
| Exelixis EXEL | $782.57M | 2025 |
| Charles River Laboratories International CRL | -$144.34M | 2025 |
The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.
Medpace Holdings, figure by figure
- Medpace Holdings market cap
- Medpace Holdings revenue
- Medpace Holdings earnings per share (EPS)
- Medpace Holdings P/E ratio
- Medpace Holdings P/S ratio
- Medpace Holdings P/B ratio
- Medpace Holdings free cash flow
- Medpace Holdings operating margin
- Medpace Holdings dividend
- Medpace Holdings shares outstanding
- Medpace Holdings total debt
- Medpace Holdings cash on hand
- Medpace Holdings total assets
- Medpace Holdings return on equity (ROE)
- Medpace Holdings return on invested capital (ROIC)
Medpace Holdings (MEDP) overview: price, valuation and scorecardAll health care companies by market value
Medpace Holdings earnings: questions and answers
What is Medpace Holdings's net income?
Medpace Holdings (MEDP) reported net income of $451.12M in fiscal 2025 (the year ended December 31, 2025). That is 11.6% higher than the $404.39M of fiscal 2024.
What is the growth rate of Medpace Holdings's net income?
Over the five fiscal years to 2025 net income grew at a compound 25.4% a year.
What are the highest and lowest net income figures on record for Medpace Holdings?
Across the 11 fiscal years on record (2015–2025), the highest was $451.12M in fiscal 2025 and the lowest -$8.67M in fiscal 2015.
How is Medpace Holdings's net income calculated?
Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.
Fiscal years are named for the calendar year they end in.
Learn: earnings
All stocks guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
Cite this page
Funkfolio, “Medpace Holdings (MEDP) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/MEDP/earnings
Underlying data: the company's filings with the SEC and Yahoo Finance.